Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
2.205
-0.055 (-2.43%)
Mar 31, 2025, 3:11 PM EDT - Market open
Heron Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 25.8 | 28.68 | 15.36 | 90.54 | 105.14 | Upgrade
|
| Short-Term Investments | 33.48 | 51.73 | 69.49 | 67.04 | 103.35 | Upgrade
|
| Cash & Short-Term Investments | 59.28 | 80.41 | 84.85 | 157.58 | 208.49 | Upgrade
|
| Cash Growth | -26.27% | -5.24% | -46.15% | -24.42% | -46.67% | Upgrade
|
| Receivables | 78.88 | 60.14 | 52.05 | 35.5 | 41.85 | Upgrade
|
| Inventory | 53.16 | 42.11 | 54.57 | 48.38 | 41.91 | Upgrade
|
| Prepaid Expenses | 17.69 | 6.12 | 13.96 | 12.96 | 21.95 | Upgrade
|
| Total Current Assets | 209.01 | 188.77 | 205.44 | 254.42 | 314.2 | Upgrade
|
| Property, Plant & Equipment | 17.65 | 25.6 | 29.81 | 33.56 | 39.01 | Upgrade
|
| Other Long-Term Assets | 6.48 | 8.13 | 15.71 | 17.72 | 0.35 | Upgrade
|
| Total Assets | 233.15 | 222.51 | 250.95 | 305.71 | 353.56 | Upgrade
|
| Accounts Payable | 11.71 | 3.24 | 3.23 | 3.8 | 0.53 | Upgrade
|
| Accrued Expenses | 76.71 | 73.37 | 76.44 | 62.26 | 89.22 | Upgrade
|
| Short-Term Debt | - | - | - | - | 7.05 | Upgrade
|
| Current Portion of Leases | 3.04 | 3.08 | 2.69 | 2.42 | 3 | Upgrade
|
| Other Current Liabilities | - | - | - | 2.58 | 2.7 | Upgrade
|
| Total Current Liabilities | 91.46 | 79.69 | 82.36 | 71.06 | 102.5 | Upgrade
|
| Long-Term Debt | 174.73 | 173.75 | 149.28 | 149.08 | - | Upgrade
|
| Long-Term Leases | - | 2.8 | 5.5 | 8 | 14.56 | Upgrade
|
| Other Long-Term Liabilities | 0.62 | 0.24 | 0.24 | - | - | Upgrade
|
| Total Liabilities | 266.8 | 256.48 | 237.38 | 228.14 | 117.06 | Upgrade
|
| Common Stock | 1.52 | 1.5 | 1.19 | 1.02 | 0.91 | Upgrade
|
| Additional Paid-In Capital | 1,884 | 1,871 | 1,808 | 1,690 | 1,628 | Upgrade
|
| Retained Earnings | -1,920 | -1,906 | -1,795 | -1,613 | -1,393 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.01 | -0.02 | -0.01 | 0.26 | Upgrade
|
| Shareholders' Equity | -33.65 | -33.97 | 13.57 | 77.57 | 236.49 | Upgrade
|
| Total Liabilities & Equity | 233.15 | 222.51 | 250.95 | 305.71 | 353.56 | Upgrade
|
| Total Debt | 177.76 | 179.63 | 157.48 | 159.5 | 24.61 | Upgrade
|
| Net Cash (Debt) | -118.48 | -99.22 | -72.63 | -1.92 | 183.88 | Upgrade
|
| Net Cash Growth | - | - | - | - | -50.46% | Upgrade
|
| Net Cash Per Share | -0.78 | -0.72 | -0.67 | -0.02 | 2.03 | Upgrade
|
| Filing Date Shares Outstanding | 152.33 | 150.33 | 119.26 | 102.14 | 91.4 | Upgrade
|
| Total Common Shares Outstanding | 152.13 | 150.29 | 119.16 | 102.01 | 91.31 | Upgrade
|
| Working Capital | 117.56 | 109.09 | 123.08 | 183.37 | 211.69 | Upgrade
|
| Book Value Per Share | -0.22 | -0.23 | 0.11 | 0.76 | 2.59 | Upgrade
|
| Tangible Book Value | -33.65 | -33.97 | 13.57 | 77.57 | 236.49 | Upgrade
|
| Tangible Book Value Per Share | -0.22 | -0.23 | 0.11 | 0.76 | 2.59 | Upgrade
|
| Machinery | 32.4 | 36.55 | 35.81 | 36.37 | 32.73 | Upgrade
|
| Leasehold Improvements | 0.31 | 0.65 | 0.65 | 0.61 | 0.88 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.